High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia
出版年份 2021 全文链接
标题
High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 9, Pages 4978
出版商
MDPI AG
发表日期
2021-05-07
DOI
10.3390/ijms22094978
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses
- (2021) Agnes Bonifacius et al. IMMUNITY
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
- (2021) Riyao Yang et al. Nature Communications
- Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
- (2021) Vincent J. Venditto et al. Frontiers in Immunology
- A neutrophil activation signature predicts critical illness and mortality in COVID-19
- (2021) Matthew L. Meizlish et al. Blood Advances
- Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia
- (2021) Luca Quartuccio et al. CYTOKINE
- Proteomic blood profiling in mild, severe and critical COVID-19 patients
- (2021) Hamel Patel et al. Scientific Reports
- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System
- (2020) Jingyue Jia et al. MOLECULAR CELL
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
- (2020) Markus Hoffmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- Cytokine storm intervention in the early stages of COVID-19 pneumonia
- (2020) Xinjuan Sun et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
- (2020) Corrado Campochiaro et al. European Journal of Internal Medicine
- Immunology of COVID-19: current state of the science
- (2020) Nicolas Vabret et al. IMMUNITY
- Ultra-high-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus (COVID-19) pneumonia
- (2020) Tae Iwasawa et al. JAPANESE JOURNAL OF RADIOLOGY
- Favipiravir, an antiviral for COVID-19?
- (2020) Eric A Coomes et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early
- (2020) Chaochao Tan et al. JOURNAL OF MEDICAL VIROLOGY
- Elevated Interleukin‐6 and Severe COVID‐19: A Meta‐Analysis
- (2020) Muhammad Aziz et al. JOURNAL OF MEDICAL VIROLOGY
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
- (2020) Jecko Thachil et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- COVID-19 update: Covid-19-associated coagulopathy
- (2020) Richard C. Becker JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Kidney disease is associated with in-hospital death of patients with COVID-19
- (2020) Yichun Cheng et al. KIDNEY INTERNATIONAL
- New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
- (2020) Francesco Bennardo et al. ORAL ONCOLOGY
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)
- (2020) Marta Colaneri et al. Microorganisms
- Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients
- (2020) Yaguang Zhang et al. Cellular & Molecular Immunology
- Acute kidney injury in critically ill patients with COVID-19
- (2020) Paul Gabarre et al. INTENSIVE CARE MEDICINE
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Molecular pharmacology of ciclesonide against SARS-CoV-2
- (2020) Hirokazu Kimura et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19
- (2020) Jeremy K. Y. Yap et al. JOURNAL OF IMMUNOLOGY
- Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis
- (2020) Roberto Rossotti et al. JOURNAL OF INFECTION
- Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
- (2020) Sara De Biasi et al. Nature Communications
- Associations Between Plasma Immunomodulatory and Inflammatory Mediators With VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy
- (2020) Thomas A. Premeaux et al. Frontiers in Immunology
- Fataler COVID-19-Verlauf trotz IL‑6‑Rezeptor-Blockade im Zytokinsturm
- (2020) M. Bovet et al. ANAESTHESIST
- Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size
- (2020) Hong Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID‐19 pneumonia
- (2020) Lara Gibellini et al. EMBO Molecular Medicine
- Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure
- (2020) T Ueland et al. JOURNAL OF INFECTION
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- Moderate Fever Cycles as a Potential Mechanism to Protect the Respiratory System in COVID-19 Patients
- (2020) Anthony Guihur et al. Frontiers in Medicine
- Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease
- (2020) Hamidreza Samaee et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Neutrophil more than platelet activation associates with thrombotic complications in COVID-19 patients
- (2020) E Petito et al. JOURNAL OF INFECTIOUS DISEASES
- Cytokine Storm
- (2020) David C. Fajgenbaum et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relationship between serum osteopontin levels and the severity of COVID-19 infection
- (2020) Ceyhun Varım et al. WIENER KLINISCHE WOCHENSCHRIFT
- The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes
- (2020) Yvonne Adu-Agyeiwaah et al. Cells
- Inhibition of inflammatory-molecule synthesis in THP-1 cells stimulated with phorbol 12-myristate 13-acetate by brefelamide derivatives
- (2019) Gaowa Bai et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Upregulation of osteopontin expression via the interaction of macrophages and fibroblasts under IL-1b stimulation
- (2018) Takahiro Shimodaira et al. CYTOKINE
- Synthesis of a Cleaved Form of Osteopontin by THP-1 Cells and Its Alteration by Phorbol 12-Myristate 13-Acetate and BCG Infection
- (2018) Gaowa Bai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of osteopontin in kidney diseases
- (2018) Beata Kaleta INFLAMMATION RESEARCH
- Serum levels of galectin-1, galectin-3 and galectin-9 are associated with large artery atherosclerotic stroke
- (2017) Xin-Wei He et al. Scientific Reports
- Utility of Plasma Osteopontin Levels in Management of Community-Acquired Pneumonia
- (2016) Jer-Hwa Chang et al. International Journal of Medical Sciences
- Plasma levels of Galectin-9 reflect disease severity in malaria infection
- (2016) Bindongo P. P. Dembele et al. MALARIA JOURNAL
- IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in ovarian cancer cells
- (2015) Minghua Zou et al. CELLULAR ONCOLOGY
- Elevated OPN, IP-10, and Neutrophilia in Loop-Mediated Isothermal Amplification Confirmed Tuberculosis Patients
- (2014) Beata Shiratori et al. MEDIATORS OF INFLAMMATION
- A Novel Cryptic Binding Motif, LRSKSRSFQVSDEQY, in the C-Terminal Fragment of MMP-3/7-Cleaved Osteopontin as a Novel Ligand for α9β1 Integrin Is Involved in the Anti-Type II Collagen Antibody-Induced Arthritis
- (2014) Shigeyuki Kon et al. PLoS One
- Elevated levels of full-length and thrombin-cleaved osteopontin during acute dengue virus infection are associated with coagulation abnormalities
- (2014) Haorile Chagan-Yasutan et al. THROMBOSIS RESEARCH
- Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection
- (2013) Haorile Chagan-Yasutan et al. JOURNAL OF CLINICAL VIROLOGY
- Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease
- (2013) Yuko Kurose et al. BMC Nephrology
- Quinolone-Induced Upregulation of Osteopontin Gene Promoter Activity in Human Lung Epithelial Cell Line A549
- (2012) Beata Shiratori et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Decrease of Plasma Galectin-9 Levels in Patients with Acute HIV Infection after Therapy
- (2012) Hiroki Saitoh et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Osteopontin Impairs Host Defense During Pneumococcal Pneumonia
- (2011) Gerritje J. W. van der Windt et al. JOURNAL OF INFECTIOUS DISEASES
- Persistent Elevation of Plasma Osteopontin Levels in HIV Patients Despite Highly Active Antiretroviral Therapy
- (2009) Haorile Chagan-Yasutan et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started